Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3003); Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3004)
Draft Resolution number 1053, 31 August 2021 (1 page(s), in Portuguese)
Proposal for a Resolution which establishes the Pilot Implementation of the Post-Market Authorization Change Management Protocol (PGMP) for drugs with synthetic and semi-synthetic active ingredients.